Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies

Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page

  1. Check
    7 days ago
    Change Detected
    Summary
    The new screenshot shows the same study detail page with only minor formatting/layout adjustments and no changes to core content such as study arms, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T12:36:56.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    36 days ago
    Change Detected
    Summary
    Major update: version bumped to v3.2.0 with a critical operating-status notice; previous version tag v3.1.0 removed.
    Difference
    1.0%
    Check dated 2025-10-05T17:28:45.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a Ubuntu-style versioning tag.
    Difference
    0.0%
    Check dated 2025-09-28T10:15:06.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-14T00:21:58.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-06T21:18:21.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as drug information for Isatuximab and Dexamethasone. Notably, the previous version's details about various locations and drug classifications have been removed.
    Difference
    2%
    Check dated 2025-08-30T15:42:48.000Z thumbnail image

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.